MAPT and Alzheimer disease: Therefore, we hypothesized that significantly increased NP-tau pathology in sleep-deprived, AD-tau–injected APPPS1:E4 mice would further disrupt their sleep rebound behavior, quantity, and quality compared with control APPPS1:E4 mice.